A European survey on treatment of hydrosalpinges in infertile women on behalf of the European Society for Gynaecological Endoscopy (ESGE) Special Interest Group (SIG) on Reproductive Surgery. by Daniilidis, A. et al.
  241
Introduction 
Tubal disease is responsible for 30-40% of cases of 
female infertility. Pathology of the fallopian tubes 
may vary from peritubal adhesions and distorted 
tubal anatomy or damaged fimbriae to hydrosalpinx 
or tubal blockage (Coughlan and Li, 2011). Pelvic 
inflammatory disease accounts for more than 50% 
of tubal disease and is likely to lead to formation 
of hydrosalpinx (Daniilidis et al., 2017).  The risk 
of infertility is about 8-12% after an episode of 
pelvic inflammatory disease and it doubles with 
each subsequent episode (Coughlan and Li, 2011). 
The most common pathogen associated with tubal 
disease is Chlamydia trachomatis (Harbet al., 
2019). Other reasons for tubal-factor infertility 
are endometriosis, a history of ectopic pregnancy 
and previous pelvic surgery (American Society 
of Reproductive Medicine, 2015). The incidence 
of hydrosalpinx in infertile women is 30%.The 
presence of hydrosalpinx is associated with lower 
pregnancy and live birth rates during an in-vitro 
fertilisation cycle. In addition, it seems to double 
the risk of biochemical pregnancy loss and triple 
the risk of ectopic pregnancy (Harbet al., 2019). A 
number of methods has been used for the diagnosis 
of tubal disease in infertile women, e.g., laparoscopy 
with dye test and transvaginal hydrolaparoscopy 
(fertiloscopy), which permit the direct visualisation 
of the pelvic organs and evaluation of tubal patency, 
and hysterosalpingography, which prevails as a 
diagnostic method for women without co-morbidities 
(such as pelvic inflammation or endometriosis) as it 
is less invasive(Gordts et al., 1998; National Institute 
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Abstract
A questionnaire-based survey was conducted among members of the European Society for Gynaecological 
Endoscopy (ESGE), with the aim of increasing awareness of the diagnosis and surgical treatment of tubal 
disease as an alternative to in-vitro fertiliszation (IVF). Seventeen participants (34%) occasionally used a test for 
prediction of the ovarian reserve before surgery, and the most commonly used test was anti-mullerian hormone 
assay (39/50; (80%). Laparoscopy was the preferred method for staging tubal disease (43/50; 86%).Thirty-seven 
(76%) participants always performed salpingectomy or tubal occlusion before the first IVF attempt. Thirty (60%) 
of the gynaecological surgeons considered the outcome with tubal surgery and IVF to be similar in mild tubal 
disease, whereas for severe disease, 31/50 (62%) felt that surgery had worse outcome. Among other factors to be 
considered in choosing a strategy for treating infertility, 20/50 (40%) of respondents listed the stage of disease. 
The findings of this survey suggest that first-line treatment for women younger than 35 years old with minor tubal 
pathology, is tubal surgery. IVF appears to be offered if there are other infertility factors, if the patient is >38 years 
old and if moderate to severe tubal disease is present.
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for Clinical Excellence and Health, 2013; American 
Society of Reproductive Medicine, 2015; Gebeh 
and Metwally, 2017).For the treatment of women 
with tubal factor infertility, assisted reproductive 
technology and endoscopic surgical approaches have 
improved in recent years (Coughlan and Li, 2011; 
Daniilidis et al., 2017). In vitro fertilisation (IVF) is 
associated with good per-cycle success rates and it is 
a less invasive method. The main disadvantages of 
IVF are the cost (especially if more than one cycle 
is required); the need for monitoring repeatedly for 
several weeks; the risks of multiple pregnancy and 
ovarian hyperstimulation syndrome; and a higher 
incidence of adverse perinatal outcomes in singleton 
infants(Daniilidis et al., 2017).Tubal surgery for 
the treatment of infertility also has advantages; it is 
usually a minimally invasive, one-time procedure that 
allows patients to attempt conception spontaneously 
without further interventions, and multiple attempts 
may be made (Daniilidis et al., 2017). On the other 
hand, surgical treatment for tubal disease is associated 
with an increased risk of surgical complications, 
such as bleeding, infection, organ damage, and 
reaction to anaesthesia; postoperative discomfort 
during the short recovery phase; and higher risk 
of ectopic pregnancy (Daniilidis et al., 2017). 
Surgical techniques used for the treatment of tubal 
disease include salpingectomy, salpingostomy, tubal 
anastomosis and tubal occlusion (American Society 
of Reproductive Medicine, 2015).This questionnaire-
based survey of members of the European Society for 
Gynaecological Endoscopy (ESGE) aimed to explore 
the currently applied practices among gynaecological 
surgeons with expertise in laparoscopic treatment of 
tubal-factor infertility. Participants of the survey were 
not specifically infertility specialists.
 
Materials and Methods 
A questionnaire survey was conducted to assess the 
approaches of members of the European Society 
for Gynaecological Endoscopy (ESGE). From 
March 1st to March 31st, 2019, ESGE members were 
invited by the ESGE Central Office to complete a 
22-item online questionnaire, accessible through the 
ESGE website. For some questions, more than one 
answer was acceptable. The invited gynaecological 
surgeons were not specifically infertility specialists, 
but they had experience in laparoscopic treatment 
of tubal-factor infertility. The participants received 
three reminders during this period. Fifty 50 
gynaecological surgeons participated in the survey.
Results
Forty-eight (96%) of the participants were 
specialists and two (4%) were trainees. Sixty per 
cent of the participants were aged 35 to 54 years; 
25(50%) were experts who performed more than 90 
laparoscopic procedures per year; and 19 (38%) had 
over 16 years of practice in endoscopic operations. 
Eighteen (36%) of the participants performed more 
than 30 laparoscopic tubal operations per year and 
22 (44%) performed 10 to 30 per year. Seventeen 
of the participants (34%) worked in a university 
teaching hospital and 25 (50%) worked in a national 
health service hospital.
According to 43 (86%) of the surveyed 
gynaecological surgeons, the best method for staging 
tubal disease was laparoscopy. Salpingectomy was 
the operation preferred by 30 (60%) participants, 
salpingoneostomy by nine (18%), tubal anastomosis 
by six (12%) and tubal occlusion by two (4%). 
Twenty-nine (58%) of the participants preferred 
bipolar energy for electrocoagulation during 
surgical treatment for tubal disease. When there is 
an incidental finding of hydrosalpinx 21(42%) of 
the gynaecological surgeons reported treatment in 
all cases; 18 (36%) reported treatment depending 
on the case; six (12%) reported no treatment; and 
4 (8%) reported treatment only in case of bilateral 
disease. When hydrosalpinx was an incidental 
finding, 43 respondents (86%) preferred to inform 
the patient first and perform second-look surgical 
treatment only when there is indication, such as pain 
or infertility.
In treatment of asymptomatic hydrosalpinx 23 
(46%) gynaecological surgeons reported using no 
routine antibiotic treatment, 18 (36%) reported 
using occasional antibiotic treatment; and five 
(10%) reported using antibiotic treatment in all 
cases. When antibiotics were used for this condition, 
20(40%) of the gynaecological surgeons seemed to 
prefer a combination of doxycycline, cephalosporin 
and penicillin, whilst 25 (50%) seemed to prefer 
doxycycline or cephalosporin only.
Twenty-two (44%) participants reported using 
a test for predicting ovarian reserve in all cases 
before tubal surgery for infertility, and 40 (80%) 
felt the most precise and reliable test for predicting 
ovarian reserve is the serum anti-Mullerian hormone 
assay. Twenty-four (48%) reported salpingectomy 
as the best method for surgical treatment of 
hydrosalpinx in case of infertility, while 17 (34%) 
prefer laparoscopic tubal occlusion, six (12%)prefer 
salpingostomy, and three (6%) prefer hysteroscopic 
tubal occlusion, with permanent micro inserts to 
cause fibrosis and irreversible tubal occlusion, 
which develop within three months of insertion. 
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and ovarian reserve (Daniilidis et al., 2017).The 
presence of hydrosalpinx in women undergoing 
an IVF cycle is associated with lower implantation 
and pregnancy rates according to retrospective 
studies (Dechaudet al., 1998;Strandellet al., 
1999; Kontoravdiset al., 2006; Minghui and Lin, 
2016) and laparoscopic salpingectomy reportedly 
improves IVF pregnancy rates (American Society of 
Reproductive Medicine, 2015; Zhang et al., 2015).
Participants in this survey seemed to concur with 
this practice, as (76%) reported that they always 
treat hydrosalpinx before the first IVF attempt and 
80% supported salpingectomy as the best surgical 
method for this indication. For women with mild 
tubal disease, a good ovarian reserve and no other 
infertility factors the prognosis of tubal surgery 
versus IVF is similar according to 60% of the 
survey answers. This opinion perhaps does not 
fully comply with literature, as it is stated that in 
case of mild tubal disease, (limited filmy adhesions, 
mildly dilated tubes, thin and pliable walls and lush 
endosalpinx with preservation of the mucosal folds) 
reconstructive tubal surgery seems to be effective, 
with a rate of spontaneous intrauterine pregnancy of 
58–77%. On the other hand, for severe tubal disease, 
62% of the gynaecological surgeons stated that tubal 
surgery is associated with worse prognosis than 
with IVF. This response is in line with evidence in 
modern literature, that surgical treatment of severe 
tubal disease (presence of extensive, dense peritubal 
adhesions; massively dilated tubes; thick, fibrotic 
walls; and sparse or absent luminal mucosa) has a 
poor prognosis, with a rate of intrauterine of 0–22% 
(Balen and Rutherford, 2007; Sacks and Trew, 
2004; National Institute for Health and Clinical 
Excellence, 2013; Gomel, 2015).
Conclusions
Based on the survey responses, first-line treatment 
for women less than 35 years old with minor tubal 
pathology seems to be tubal surgery. IVF appears to 
be offered when there are other infertility factors, 
if the patient is >38 years old, and when moderate-
to-severe tubal disease is present. According to the 
surveyed laparoscopic surgeons, tubal surgery and 
assisted reproductive technology in most of the 
cases are not competitive techniques, but usually 
tubal surgery is a prerequisite for the success of 
the IVF. Optimizing pregnancy rates and reducing 
the risks associated with IVF or surgical treatment 
should always be the main goal. The outcome of 
our survey is especially meaningful because of 
the high level of expertise in laparoscopic surgery 
and the high level of expertise in the laparoscopic 
treatment of hydrosalpinx among the participating 
Thirty-seven (76%) participants always performed 
surgical treatment of hydrosalpinx before the first 
IVF attempt, and 40 (80%) supported salpingectomy 
as being the best operative method regarding the 
outcome of a following IVF attempt. For women 
with mild tubal disease, good ovarian reserve and 
no other infertility factors, the prognosis of tubal 
surgery versus IVF is similar according to 30(60%) 
respondents. For women with moderate tubal disease 
19(38%) participants felt that surgery and IVF had 
similar outcomes, and 17 (34%) felt that surgery 
had worse outcomes. In the treatment of severe 
tubal disease, 31 (62%) gynaecological surgeons 
stated that tubal surgery has worse outcomes than 
IVF. Twenty-two (44%) of participants reported 
that the combination of both methods imposes 
higher cost. Finally, according to 20 (40%) of the 
surveyed gynaecological surgeons, the stage of 
tubal disease is the first factor to take into account 
when considering strategies for treating infertility, 
whereas 30 (60%) felt that age and other infertility 
factors  are most important.
Discussion
The results of this survey of 50 members of 
the ESGE on surgical treatment of tubal-factor 
infertility are comparable to the published literature 
on this subject. Thirty-eight (76%) participants 
favoured laparoscopy as the ideal method for the 
evaluation of tubal patency and the diagnosis of 
tubal disease, which is in line with reported practice 
(Coughlan and Li, 2011;Gebeh and Metwally, 
2017). Almost two-thirds of the participants perform 
laparoscopic salpingectomy or tubal occlusion, 
which is recommended in cases of tubal disease 
that may have a detrimental effect on the fallopian 
tube patency and on in vitro fertilization outcome 
(American Society of Reproductive Medicine, 
2015).The use of bipolar diathermy seems to be 
preferable to monopolar diathermy according to 
the surgeons participating in this survey, which 
is in line with a report of bipolar diathermy being 
the safer method (Saridogan et al., 2017). Almost 
half the participants reported using no antibiotics in 
the treatment of asymptomatic hydrosalpinx, and 
only 10% reported using antibiotic treatment in 
all cases. This response corresponds with a report 
that tubal damage and infertility persist in 8-12% 
of chlamydia cases even after successful antibiotic 
treatment (Coughlan and Li, 2011). Twenty-two 
(44%) participants use a test for predicting the 
ovarian reserve in all cases before tubal surgery for 
infertility. That is in line with modern literature, 
which reports that surgery for tubal disease may 
be associated with damage to ovarian blood flow 
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gynaecological surgeons. On the other hand, the 
insufficient number of participants is a drawback, 
which points out the need for a future survey, 
better designed and with more gynaecologists with 
experience in laparoscopic treatment of tubal-factor 
infertility. Such a survey would minimize bias and 
produce clear answers and recommendations.
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